Clinical Trial Update: Study on the Sex-specific, Lipid- and Lipoprotein-lowering Effects of Berberine [Phase 2, Phase 3]

View source ↗

Summary

This entry notes an ongoing Phase 2/3 clinical trial evaluating berberine for sex-specific lipid- and lipoprotein-lowering effects in individuals with hyperlipi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipidemia

Drugs mentioned

• Berberine (berberine)

Snippet

Sponsor: The University of Hong Kong | Conditions: Hyperlipidemia | Phase 2, Phase 3 | Status: ENROLLING_BY_INVITATION